Journal of Geriatric Cardiology
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q3
WOS
Q3
Impact factor
1.8
SJR
0.509
CiteScore
3.3
Categories
Cardiology and Cardiovascular Medicine
Geriatrics and Gerontology
Areas
Medicine
Years of issue
2006-2024
journal names
Journal of Geriatric Cardiology
J GERIATR CARDIOL
Top-3 citing journals

Frontiers in Cardiovascular Medicine
(26 citations)

International Journal of Cardiology
(23 citations)
Journal of Geriatric Cardiology
(19 citations)
Top-3 organizations

Curtin University
(4 publications)

Peking University
(2 publications)
Most cited in 5 years
Found
Publications found: 344
Q2

Is early use of sodium-glucose cotransporter type 2 inhibitor (SGLT2i) necessary even in diabetic patients without cardiovascular disease: a prospective study regarding the effect of SGLT2i on left ventricular diastolic function
Jeon K., Jang S.Y., Lee Y., Kim J., Kim D., Chang S., Park S., Lee S., Park S.W., Lee M., Kim E.K., Hur K.Y.
Abstract
Background
There are insufficient studies to determine whether sodium-glucose cotransporter type 2 inhibitors (SGLT2i) will help reduce early diabetic cardiomyopathy, especially in patients without documented cardiovascular disease.
Methods
We performed a single center, prospective observation study. A total of 90 patients with type 2 diabetes patients without established heart failure or atherosclerotic cardiovascular disease were enrolled. Echocardiography, cardiac enzyme, and glucose-control data were examined before and 3 months after the administration of SGLT2i (dapagliflozin 10 mg per day). Cardiovascular risk factors included hypertension, smoking, obesity, dyslipidemia, and old age. The primary end point was the change of E/e’ before and after administration of SGLT2i.
Results
Most patients (86.7%) had three or more cardiovascular risk factors, and about 32% had all five risk factors. Although the decrease in E/e’ after the administration of SGLT2i was observed in 20% of enrolled patients, there was no significant difference in average E/e’ value or left atrial volume index before and after the SGLT2i medication. Even in patients with all known risk factors including old age, E/e’ value did not decrease after adding SGLT2i (8.9 ± 2.4 vs. 8.7 ± 3.2). There was a statistically significant difference in E/e’ change after the SGLT2i administration between patients younger than 60 years and those older than 60 years (–0.7 ± 2.2 vs. 1.1 ± 2.8, P = 0.002).
Conclusions
In type 2 diabetes patients without documented cardiovascular disease including heart failure, administration of SGLT2i showed no improvement in diastolic function profile. Further large-scale randomized studies are needed to determine who will benefit from potential cardiovascular events with early addition of SGLT2i.
Q2

Real-time three-dimensional transthoracic echocardiographic segmental volume analysis: a quantitative and objective tool for assessing regional left ventricle wall motion in patients with ischemic heart disease
Kwak J., Choi K., Park J., Nam J., Lee C., Kim U., Park J., Son J.
Abstract
Background
Evaluation of regional left ventricle function using two-dimensional echocardiography (2DE) in patients with ischemic heart disease has limitations due to its low objectivity and qualitative nature. In addition, 2DE is limited because multiple acoustic windows are used to obtain the image, whereas three-dimensional echocardiography (3DE) uses a single window. This study aims to demonstrate the clinical utility of 3DE segmental volume analysis for evaluating regional wall motion abnormality (RWMA).
Methods
This retrospective study included 33 patients with ischemic heart disease and single-vessel territory RWMA confirmed on coronary angiography. RWMA was visually assessed using 2DE, generating 17-segment bull's-eye polar maps, and 3DE. In the 3DE study, two independent observers analyzed segmental volumes and segmental volume ejection fractions (SVEFs) using QLAB 3D quantification software. The optimal SVEF cutoff value differentiating normal from abnormal was determined using receiver operating curve analysis. The accuracy of 3DE in predicting culprit coronary arteries was compared with that of 2DE using Cohen κ coefficients, which also were used for interobserver and intraobserver variability assessments.
Results
Mean 3DE SVEFs were significantly lower in segments showing RWMA on 2DE. The optimal SVEF cutoff value was 44%, with sensitivity of 75.0% and specificity of 73.9% (area under the curve, 0.801; 95% CI, 0.763–0.838; P < 0.001). The reliability of 3DE-derived bull's-eye predictions of culprit coronary arteries was 81.8% (κ = 0.672; 95% CI, 0.555–0.789; P < 0.001). Interobserver and intraobserver variabilities were 97.0% (κ = 0.947; 95% CI, 0.894–1.00; P < 0.001) and 93.9% (κ = 0.897; 95% CI, 0.827–0.967; P < 0.001), respectively.
Conclusions
The 3DE segmental volume analysis effectively quantified regional left ventricle function and aligned well with 2DE and coronary angiography findings in predicting culprit coronary arteries. Thus, 3DE segmental volume analysis can serve as a quantitative and objective tool for RWMA assessment in patients with ischemic heart disease.
Q2

Aortic valve sclerosis is not a benign finding but progressive disease associated with poor cardiovascular outcomes
Seo J.H., Chun K.J., Lee B., Cho B., Ryu D.R.
Abstract
Background
Aortic valve sclerosis (AVS) shares risk factors with atherosclerosis. However, the relationship between AVS progression with cardiovascular (CV) risk has not been researched. This study investigates CV outcomes according to progression of AVS.
Methods
This study included 2,901 patients with AVS (irregular leaflet thickening and peak aortic jet velocity < 2 m/sec) who underwent serial echocardiograms at least 1 year apart during 2011–2020. The primary outcome was defined as CV death, myocardial infarction, stroke, or revascularization.
Results
During a median follow-up period of 3.9 years, 439 of 2,901 AVS patients (15.1%) progressed to mild or greater aortic stenosis. Patients with progression were older and more likely to have atrial fibrillation than those without. In a stepwise regression, age (odds ratio [OR] per 1-year increase, 1.04; 95% confidence interval [CI], 1.01–1.07), peripheral artery disease (OR, 9.07; 95% CI, 3.12–26.4), and left ventricular mass index (OR per 1-g/m2 increase, 1.01; 95% CI, 1.00–1.02) were associated with AVS progression. Over a median of 6.3 years, the primary outcome occurred in 858 of 2,901 patients (29.6%). Patients with progression had higher frequency of CV death, myocardial infarction, stroke, or revascularization than those without progression (P < 0.0001). In Cox proportional hazards regression, AVS progression (hazard ratio, 1.33; 95% CI, 1.10–1.61) was a significant determinant of CV mortality.
Conclusions
The progression to aortic stenosis in AVS patients is an independent risk factor for CV mortality. These findings suggest that patients with AVS progression may benefit from stricter CV risk monitoring.
Q2

The impact of regional impairment of longitudinal strain and regurgitant jet in aortic regurgitation on myocardial mechanics and postoperative recovery
Hwang J.
Q2
Journal of Cardiovascular Imaging
,
2024
,
citations by CoLab: 0

Q2

Contemporary diagnosis and treatment of valvular heart disease in Korea: a nationwide hospital-based registry study
Kim H.Y., Lee H.J., Kim I., Son J., Park J., Lee S., Kim E.K., Park S., Chung W., Cho J.S., Park J., Seo J., Lee S.H., Sun B.J., Shim C.Y., et. al.
Abstract
Background
This study was designed to determine the current status of diagnosis and treatment of valvular heart disease (VHD) in Korea.
Methods
A nationwide registry study was conducted in 45 hospitals in Korea involving adult patients with at least moderate VHD as determined by echocardiography carried out between September and October of 2019. Of a total of 4,094 patients with at least moderate VHD, 1,482 had severe VHD (age, 71.3 ± 13.5 years; 49.1% male). Echocardiographic data used for the diagnosis of each case of VHD were analyzed. Experts from each center determined the diagnosis and treatment strategy for VHD based on current guidelines and institutional policy. The clinical outcome was in-hospital mortality.
Results
Each valve underwent surgical or transcatheter intervention in 19.3% cases of severe mitral stenosis, 31.4% cases of severe primary mitral regurgitation (MR), 7.5% cases of severe secondary MR, 43.7% cases of severe aortic stenosis, 27.5% cases of severe aortic regurgitation, and 7.2% cases of severe tricuspid regurgitation. The overall in-hospital mortality rate for patients with severe VHD was 5.4%, and for secondary severe MR and severe tricuspid regurgitation, the rates were 9.0% and 7.5%, respectively, indicating a poor prognosis. In-hospital mortality occurred in 73 of the 1,244 patients (5.9%) who received conservative treatment and in 18 of the 455 patients (4.0%) who received a surgical or transcatheter intervention, which was significantly lower in the intervention group (P = 0.037).
Conclusions
This study provides important information about the current status of VHD diagnosis and treatment through a nationwide registry in Korea and helps to define future changes.
Q2

Efficacy of routine contrast echocardiography for the detection of left ventricular thrombus in patients with anterior ST-elevation myocardial infarction
Hwang H., Sohn I.S.
Q2
Journal of Cardiovascular Imaging
,
2024
,
citations by CoLab: 0

Q2

Global longitudinal strain manually measured from mid-myocardial lengths is a reliable alternative to speckle tracking global longitudinal strain
Yeong C.C., Harrop D.L., Ng A.C., Wang W.Y.
Abstract
Background
Global longitudinal strain (GLS) is a useful marker for the echocardiographic evaluation of left ventricular (LV) systolic dysfunction. Presently GLS is derived from speckle tracking of LV images, but speckle tracking software is not always available. We seek to determine if manually measured GLS (MM-GLS) by assessing mid-myocardial lengths can be a reliable alternative to speckle tracking GLS (ST-GLS).
Methods
Transthoracic echocardiogram images of a tertiary hospital in Australia were retrospectively analyzed to study the relationships between ST-GLS, MM-GLS, and LV ejection fraction (LVEF). We further evaluated the impact of image quality and regional wall motion abnormalities on those relationships.
Results
Echocardiography studies from 154 patients were included (female sex, 36%; mean age, 61.7 ± 14.8 years). The average LVEF was 51.3% ± 11.3% and the average ST-GLS was 16.7 ± 3.8. MM-GLS strongly correlated with ST-GLS (intraclass correlation coefficient, 0.986; P < 0.001) and with LVEF regardless of the presence of regional wall motion abnormalities. If using GLS cutoff of more than 18% as normal, 97.5% of studies with normal ST-GLS had normal MM-GLS. If using GLS cutoff as less than 16% as abnormal, 95.5% of studies with abnormal ST-GLS had abnormal MM-GLS. There was no case with ST-GLS > 18% and MM-GLS < 16%, nor were there any case in with ST-GLS < 16% and MM-GLS > 18%.
Conclusions
MM-GLS correlates strongly with ST-GLS. If ST-GLS cannot be accurately assessed, MM-GLS may be a useful alternative to provide GLS values in both clinical and research studies.
Q2

Correction: 2023 Korean Society of Echocardiography position paper for diagnosis and management of valvular heart disease, part I: aortic valve disease
Lee S.H., Yoon S.J., Sun B.J., Kim H.M., Kim H.Y., Lee S., Shim C.Y., Kim E.K., Cho D.H., Park J.B., Seo J.S., Son J.W., Kim I.C., Lee S.H., Heo R., et. al.
Q2
Journal of Cardiovascular Imaging
,
2024
,
citations by CoLab: 0

Q2

Usefulness and importance of echocardiography in the diagnosis of pediatric pulmonary hypertension
Choi H.J.
Q2
Journal of Cardiovascular Imaging
,
2024
,
citations by CoLab: 0

Q2

To see those not to be seen: cardiac uptake on noncardiac imaging
Cho S.
Q2
Journal of Cardiovascular Imaging
,
2024
,
citations by CoLab: 0

Q2

Speckle tracking echocardiography: a reliable tool for right ventricle function evaluation in severe tricuspid regurgitation
Lee J.
Q2
Journal of Cardiovascular Imaging
,
2024
,
citations by CoLab: 0

Q2

Super-resolution deep learning image reconstruction: image quality and myocardial homogeneity in coronary computed tomography angiography
Otgonbaatar C., Kim H., Jeon P., Jeon S., Cha S., Ryu J., Jung W.B., Shim H., Ko S.M.
Abstract
Background
The recently introduced super-resolution (SR) deep learning image reconstruction (DLR) is potentially effective in reducing noise level and enhancing the spatial resolution. We aimed to investigate whether SR-DLR has advantages in the overall image quality and intensity homogeneity on coronary computed tomography (CT) angiography with four different approaches: filtered-back projection (FBP), hybrid iterative reconstruction (IR), DLR, and SR-DLR.
Methods
Sixty-three patients (mean age, 61 ± 11 years; range, 18–81 years; 40 men) who had undergone coronary CT angiography between June and October 2022 were retrospectively included. Image noise, signal to noise ratio, and contrast to noise ratio were quantified in both proximal and distal segments of the major coronary arteries. The left ventricle myocardium contrast homogeneity was analyzed. Two independent reviewers scored overall image quality, image noise, image sharpness, and myocardial homogeneity.
Results
Image noise in Hounsfield units (HU) was significantly lower (P < 0.001) for the SR-DLR (11.2 ± 2.0 HU) compared to those associated with other image reconstruction methods including FBP (30.5 ± 10.5 HU), hybrid IR (20.0 ± 5.4 HU), and DLR (14.2 ± 2.5 HU) in both proximal and distal segments. SR-DLR significantly improved signal to noise ratio and contrast to noise ratio in both the proximal and distal segments of the major coronary arteries. No significant difference was observed in the myocardial CT attenuation with SR-DLR among different segments of the left ventricle myocardium (P = 0.345). Conversely, FBP and hybrid IR resulted in inhomogeneous myocardial CT attenuation (P < 0.001). Two reviewers graded subjective image quality with SR-DLR higher than other image reconstruction techniques (P < 0.001).
Conclusions
SR-DLR improved image quality, demonstrated clearer delineation of distal segments of coronary arteries, and was seemingly accurate for quantifying CT attenuation in the myocardium.
Q2

Regional impairment of left ventricular longitudinal strain in aortic regurgitation
Ferreira J., Marta L., Presume J., Freitas P., Guerreiro S., Abecasis J., Reis C., Ribeiras R., Mendes M., Andrade M.J.
Abstract
Background
Aortic regurgitation (AR) has an important impact on myocardial mechanics and recent studies have proved the value of global longitudinal strain (GLS) in the assessment of its severity and prognosis. Our purpose was to assess if the direct impact of the regurgitant jet on the myocardial wall could affect regional longitudinal strain.
Methods
Eighty patients with chronic moderate/severe AR were retrospectively studied. Patients were considered to have a jet-related longitudinal strain reduction when the myocardial segments directly impacted by the jet had their longitudinal strain reduced by at least 30% compared to nonaffected segments. AR severity, left ventricular (LV) size and function were compared according to the presence/absence of this regional pattern. For those who underwent surgery, postoperative regional and global LV function was also analyzed.
Results
A pattern of regional longitudinal strain impairment was identified in 43% of patients, with a regional reduction (in median) of 10 percentage points in absolute strain values in the segments impacted by the jet, compared to nonaffected segments. In the subgroup who underwent surgery, this pattern became attenuated after surgery. Patients with regional longitudinal strain impairment were less likely to improve GLS after surgery (10% vs. 38% improved GLS by at least 2.5%, P = 0.049).
Conclusions
To our knowledge, this study identifies for the first time, a link between the location of the impact of the regurgitant jet in AR and regional longitudinal strain impairment. The presence of this regional pattern might be associated with worse postoperative LV recovery.
Q2

Images in cardiovascular disease: a rare case of perforated abscess of mitral valve after Infective Endocarditis (IE)
Niedźwiedzka A., Pawlak A., Suwalski P., Gil R.
Q2
Journal of Cardiovascular Imaging
,
2024
,
citations by CoLab: 0

Q2

Preprocedural cardiac computed tomography versus transesophageal echocardiography for planning left atrial appendage occlusion procedures
Soh B.W., Gracias C.S., Sim W.H., Killip M., Waters M., Millar K.P., O’Brien J.M., Kiernan T.J., Arnous S.
AbstractThe heterogeneous anatomy of the left atrial appendage (LAA) necessitates preprocedural imaging essential for planning of percutaneous LAA occlusion (LAAO) procedures. While transoesophageal echocardiography (TOE) remains the gold standard, cardiac computed tomography (CT) is becoming increasingly popular. To address the lack of consensus on the optimal imaging modality, we compared the outcomes of preprocedural TOE versus CT for LAAO procedure planning. A retrospective single-center cohort study of all LAAO procedures was performed to compare the outcomes of patients receiving preprocedural TOE versus those receiving CT. The primary outcome was procedural success and rate of major adverse events. The secondary outcomes were total procedure time, rate of device size change, and maximum landing zone diameter. A total of 64 patients was included. Of these, 25 (39.1%) underwent TOE and 39 (60.9%) underwent CT. There was no significant difference in the procedural success rate (96.0% vs. 100%, P = 0.39) or major adverse event rate (4.0% vs. 5.1%, P > 0.99) between TOE and CT patients. Compared with TOE, CT was associated with significantly shorter median procedure time (103 min vs. 124 min, P = 0.02) and a lower rate of device size change (7.7% vs. 28.0%, P = 0.04). Compared to CT, TOE was associated with a significantly smaller mean maximum landing zone diameter (20.8 mm vs. 25.8 mm, P < 0.01) and a higher rate of device upsizing (24.0% vs. 2.6%, P = 0.01). No significant difference in detected residual leak rates was found between TOE and CT (50.0% vs. 52.2%, P > 0.99). Planning of LAAO procedures with CT is associated with a shorter total procedure time and a lower rate of device size change and is less likely to underestimate the maximum landing zone diameter.
Top-100
Citing journals
5
10
15
20
25
30
|
|
Frontiers in Cardiovascular Medicine
26 citations, 1.76%
|
|
International Journal of Cardiology
23 citations, 1.56%
|
|
Journal of Geriatric Cardiology
19 citations, 1.29%
|
|
Scientific Reports
16 citations, 1.08%
|
|
Medicine (United States)
14 citations, 0.95%
|
|
PLoS ONE
14 citations, 0.95%
|
|
BMC Cardiovascular Disorders
12 citations, 0.81%
|
|
International Journal of Molecular Sciences
11 citations, 0.75%
|
|
Cureus
11 citations, 0.75%
|
|
Journal of Clinical Medicine
11 citations, 0.75%
|
|
Molecular Medicine Reports
10 citations, 0.68%
|
|
Frontiers in Pharmacology
10 citations, 0.68%
|
|
British Journal of Cardiac Nursing
9 citations, 0.61%
|
|
Journal of Cardiothoracic Surgery
8 citations, 0.54%
|
|
Biomedicine and Pharmacotherapy
8 citations, 0.54%
|
|
Lipids in Health and Disease
7 citations, 0.47%
|
|
Life Sciences
7 citations, 0.47%
|
|
Angiology
7 citations, 0.47%
|
|
American Journal of Cardiology
7 citations, 0.47%
|
|
Frontiers in Physiology
7 citations, 0.47%
|
|
BMC Public Health
7 citations, 0.47%
|
|
European Journal of Cardiovascular Nursing
7 citations, 0.47%
|
|
Reactions Weekly
7 citations, 0.47%
|
|
Journal of Psychosomatic Research
6 citations, 0.41%
|
|
Clinical Cardiology
6 citations, 0.41%
|
|
Journal of the American Heart Association
6 citations, 0.41%
|
|
BMJ Open
6 citations, 0.41%
|
|
ESC heart failure
6 citations, 0.41%
|
|
Nutrition, Metabolism and Cardiovascular Diseases
6 citations, 0.41%
|
|
Journal of Cardiovascular Nursing
6 citations, 0.41%
|
|
Heliyon
6 citations, 0.41%
|
|
Journal of Cardiac Failure
5 citations, 0.34%
|
|
Journal of Cardiovascular Pharmacology
5 citations, 0.34%
|
|
Frontiers in Endocrinology
5 citations, 0.34%
|
|
Journal of Vascular Surgery
5 citations, 0.34%
|
|
Evidence-based Complementary and Alternative Medicine
5 citations, 0.34%
|
|
Experimental and Therapeutic Medicine
5 citations, 0.34%
|
|
International Journal of Environmental Research and Public Health
4 citations, 0.27%
|
|
Nutrients
4 citations, 0.27%
|
|
Heart Lung and Circulation
4 citations, 0.27%
|
|
Nature Reviews Cardiology
4 citations, 0.27%
|
|
International Journal of Surgery
4 citations, 0.27%
|
|
European Geriatric Medicine
4 citations, 0.27%
|
|
Journal of Clinical Hypertension
4 citations, 0.27%
|
|
Cardiovascular Research
4 citations, 0.27%
|
|
Complementary Therapies in Clinical Practice
4 citations, 0.27%
|
|
Annals of Thoracic Surgery
4 citations, 0.27%
|
|
Atherosclerosis
4 citations, 0.27%
|
|
Clinical Interventions in Aging
4 citations, 0.27%
|
|
American Journal of Cardiovascular Drugs
4 citations, 0.27%
|
|
Pharmacology and Therapeutics
4 citations, 0.27%
|
|
Journal of the American Medical Directors Association
3 citations, 0.2%
|
|
European Journal of Pharmacology
3 citations, 0.2%
|
|
PeerJ
3 citations, 0.2%
|
|
Archives of Gerontology and Geriatrics
3 citations, 0.2%
|
|
Heart and Lung: Journal of Acute and Critical Care
3 citations, 0.2%
|
|
Frontiers in Psychology
3 citations, 0.2%
|
|
Journal of Molecular and Cellular Cardiology
3 citations, 0.2%
|
|
American Journal of the Medical Sciences
3 citations, 0.2%
|
|
Revista Espanola de Geriatria y Gerontologia
3 citations, 0.2%
|
|
Cardiovascular Toxicology
3 citations, 0.2%
|
|
European Heart Journal
3 citations, 0.2%
|
|
European heart journal. Quality of care & clinical outcomes
3 citations, 0.2%
|
|
BMC Geriatrics
3 citations, 0.2%
|
|
Aging clinical and experimental research
3 citations, 0.2%
|
|
BioMed Research International
3 citations, 0.2%
|
|
European Heart Journal: Acute Cardiovascular Care
3 citations, 0.2%
|
|
BMC Health Services Research
3 citations, 0.2%
|
|
Circulation Journal
3 citations, 0.2%
|
|
Clinics in Geriatric Medicine
3 citations, 0.2%
|
|
PACE - Pacing and Clinical Electrophysiology
3 citations, 0.2%
|
|
American Journal of Emergency Medicine
3 citations, 0.2%
|
|
Journal of Materials Chemistry B
3 citations, 0.2%
|
|
Molecular and Cellular Biochemistry
3 citations, 0.2%
|
|
Drugs and Aging
3 citations, 0.2%
|
|
Journal of Atherosclerosis and Thrombosis
3 citations, 0.2%
|
|
Frontiers in Public Health
3 citations, 0.2%
|
|
Annals of Noninvasive Electrocardiology
3 citations, 0.2%
|
|
Acta Pharmacologica Sinica
3 citations, 0.2%
|
|
Journal of Ethnopharmacology
3 citations, 0.2%
|
|
Revista Portuguesa de Cardiologia
3 citations, 0.2%
|
|
Expert Opinion on Drug Safety
3 citations, 0.2%
|
|
Internal Medicine
3 citations, 0.2%
|
|
Journal of Cardiovascular Electrophysiology
3 citations, 0.2%
|
|
World Journal of Surgery
3 citations, 0.2%
|
|
Public Health
3 citations, 0.2%
|
|
Cardiovascular Therapy and Prevention (Russian Federation)
3 citations, 0.2%
|
|
Psychosomatic Medicine
3 citations, 0.2%
|
|
Annals of Vascular Surgery
3 citations, 0.2%
|
|
Progress in Cardiovascular Diseases
3 citations, 0.2%
|
|
Diagnostics
3 citations, 0.2%
|
|
Circulation: Cardiovascular Quality and Outcomes
3 citations, 0.2%
|
|
Journal of the American College of Cardiology
3 citations, 0.2%
|
|
Canadian Journal of Cardiology
3 citations, 0.2%
|
|
Current Problems in Cardiology
3 citations, 0.2%
|
|
Cancers
3 citations, 0.2%
|
|
American Journal of Physiology - Heart and Circulatory Physiology
3 citations, 0.2%
|
|
EuroIntervention
3 citations, 0.2%
|
|
Journal of Interventional Cardiac Electrophysiology
3 citations, 0.2%
|
|
Molecular Neurobiology
3 citations, 0.2%
|
|
Show all (70 more) | |
5
10
15
20
25
30
|
Citing publishers
50
100
150
200
250
300
350
|
|
Elsevier
347 citations, 23.51%
|
|
Springer Nature
278 citations, 18.83%
|
|
Wiley
96 citations, 6.5%
|
|
MDPI
71 citations, 4.81%
|
|
Frontiers Media S.A.
71 citations, 4.81%
|
|
Ovid Technologies (Wolters Kluwer Health)
65 citations, 4.4%
|
|
SAGE
55 citations, 3.73%
|
|
Taylor & Francis
45 citations, 3.05%
|
|
Oxford University Press
32 citations, 2.17%
|
|
Hindawi Limited
20 citations, 1.36%
|
|
China Science Publishing & Media
18 citations, 1.22%
|
|
Spandidos Publications
17 citations, 1.15%
|
|
BMJ
16 citations, 1.08%
|
|
Public Library of Science (PLoS)
14 citations, 0.95%
|
|
Bentham Science Publishers Ltd.
12 citations, 0.81%
|
|
Mark Allen Group
12 citations, 0.81%
|
|
Cold Spring Harbor Laboratory
9 citations, 0.61%
|
|
Mary Ann Liebert
8 citations, 0.54%
|
|
8 citations, 0.54%
|
|
Institute of Electrical and Electronics Engineers (IEEE)
8 citations, 0.54%
|
|
JMIR Publications
8 citations, 0.54%
|
|
Royal Society of Chemistry (RSC)
6 citations, 0.41%
|
|
Georg Thieme Verlag KG
6 citations, 0.41%
|
|
American Physiological Society
6 citations, 0.41%
|
|
The Japanese Circulation Society
6 citations, 0.41%
|
|
The Heart Failure Association of the European Society of Cardiology
5 citations, 0.34%
|
|
Silicea - Poligraf, LLC
5 citations, 0.34%
|
|
Medknow
4 citations, 0.27%
|
|
S. Karger AG
4 citations, 0.27%
|
|
OAE Publishing Inc.
4 citations, 0.27%
|
|
Cambridge University Press
3 citations, 0.2%
|
|
Walter de Gruyter
3 citations, 0.2%
|
|
World Scientific
3 citations, 0.2%
|
|
American Chemical Society (ACS)
3 citations, 0.2%
|
|
Pleiades Publishing
3 citations, 0.2%
|
|
Impact Journals
3 citations, 0.2%
|
|
PeerJ
3 citations, 0.2%
|
|
IOP Publishing
3 citations, 0.2%
|
|
The Endocrine Society
3 citations, 0.2%
|
|
American Medical Association (AMA)
3 citations, 0.2%
|
|
Japan Atherosclerosis Society
3 citations, 0.2%
|
|
Europa Ed
3 citations, 0.2%
|
|
Scientific Research Publishing
3 citations, 0.2%
|
|
Japanese Society of Internal Medicine
3 citations, 0.2%
|
|
Research Square Platform LLC
3 citations, 0.2%
|
|
King Saud University
2 citations, 0.14%
|
|
AIP Publishing
2 citations, 0.14%
|
|
2 citations, 0.14%
|
|
Eco-Vector LLC
2 citations, 0.14%
|
|
The Korean Society of Genetics
2 citations, 0.14%
|
|
Tsinghua University Press
2 citations, 0.14%
|
|
Cardiological Society of India
2 citations, 0.14%
|
|
Federation of American Societies for Experimental Biology (FASEB)
2 citations, 0.14%
|
|
Indian Pacing and Electrophysiology Group
2 citations, 0.14%
|
|
Sociedade Portuguesa De Cardiologia
2 citations, 0.14%
|
|
Canadian Science Publishing
2 citations, 0.14%
|
|
2 citations, 0.14%
|
|
Maad Rayan Publishing Company
2 citations, 0.14%
|
|
Media Sphere Publishing House
2 citations, 0.14%
|
|
Baishideng Publishing Group
2 citations, 0.14%
|
|
IGI Global
2 citations, 0.14%
|
|
F1000 Research
2 citations, 0.14%
|
|
APO Society of Specialists in Heart Failure
2 citations, 0.14%
|
|
XMLink
2 citations, 0.14%
|
|
International Heart Journal (Japanese Heart Journal)
2 citations, 0.14%
|
|
IOS Press
1 citation, 0.07%
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 citation, 0.07%
|
|
American Diabetes Association
1 citation, 0.07%
|
|
1 citation, 0.07%
|
|
1 citation, 0.07%
|
|
American Society for Clinical Investigation
1 citation, 0.07%
|
|
American Society for Pharmacology and Experimental Therapeutics
1 citation, 0.07%
|
|
Portland Press
1 citation, 0.07%
|
|
American Society of Nephrology
1 citation, 0.07%
|
|
Index Copernicus
1 citation, 0.07%
|
|
Health Affairs (Project Hope)
1 citation, 0.07%
|
|
Association for Computing Machinery (ACM)
1 citation, 0.07%
|
|
Edizioni Minerva Medica
1 citation, 0.07%
|
|
AME Publishing Company
1 citation, 0.07%
|
|
American Association for Cancer Research (AACR)
1 citation, 0.07%
|
|
Australian Society of Anaesthetists
1 citation, 0.07%
|
|
Tohoku University Medical Press
1 citation, 0.07%
|
|
Korean Society of Exercise Rehabilitation
1 citation, 0.07%
|
|
1 citation, 0.07%
|
|
Society for Neuroscience
1 citation, 0.07%
|
|
American Thoracic Society
1 citation, 0.07%
|
|
European Respiratory Society (ERS)
1 citation, 0.07%
|
|
Korean Society of Circulation
1 citation, 0.07%
|
|
1 citation, 0.07%
|
|
Aran Ediciones SA
1 citation, 0.07%
|
|
1 citation, 0.07%
|
|
American Society for Nutrition
1 citation, 0.07%
|
|
Siberian State Medical University
1 citation, 0.07%
|
|
Vilnius University Press
1 citation, 0.07%
|
|
1 citation, 0.07%
|
|
Consilium Medicum
1 citation, 0.07%
|
|
Medicine Publishing
1 citation, 0.07%
|
|
Silvia Tanno
1 citation, 0.07%
|
|
Open Access Macedonian Journal of Medical Sciences
1 citation, 0.07%
|
|
1 citation, 0.07%
|
|
Show all (70 more) | |
50
100
150
200
250
300
350
|
Publishing organizations
2
4
6
8
10
12
14
16
|
|
People's Liberation Army General Hospital and Medical School (301 Hospital)
16 publications, 5.44%
|
|
Curtin University
4 publications, 1.36%
|
|
Peking University
2 publications, 0.68%
|
|
Xi'an Jiaotong University
2 publications, 0.68%
|
|
Capital Medical University
2 publications, 0.68%
|
|
Tomsk National Research Medical Center of the Russian Academy of Sciences
1 publication, 0.34%
|
|
Suleyman Demirel University
1 publication, 0.34%
|
|
Canakkale Onsekiz Mart University
1 publication, 0.34%
|
|
Huazhong University of Science and Technology
1 publication, 0.34%
|
|
Fudan University
1 publication, 0.34%
|
|
Tel Aviv Sourasky Medical Center
1 publication, 0.34%
|
|
University of Malaya
1 publication, 0.34%
|
|
Nanjing University
1 publication, 0.34%
|
|
University of Gothenburg
1 publication, 0.34%
|
|
Skåne University Hospital
1 publication, 0.34%
|
|
Nankai University
1 publication, 0.34%
|
|
Hebei Medical University
1 publication, 0.34%
|
|
Peking Union Medical College Hospital
1 publication, 0.34%
|
|
University Hospital of Basel
1 publication, 0.34%
|
|
Istituti di Ricovero e Cura a Carattere Scientifico
1 publication, 0.34%
|
|
Università Cattolica del Sacro Cuore
1 publication, 0.34%
|
|
University of Milan
1 publication, 0.34%
|
|
Tzu Chi University
1 publication, 0.34%
|
|
Shenyang Medical College
1 publication, 0.34%
|
|
Zunyi Medical University
1 publication, 0.34%
|
|
Agostino Gemelli University Polyclinic
1 publication, 0.34%
|
|
University of Modena and Reggio Emilia
1 publication, 0.34%
|
|
Qingdao University
1 publication, 0.34%
|
|
University of Otago
1 publication, 0.34%
|
|
University of Western Australia
1 publication, 0.34%
|
|
Flinders University
1 publication, 0.34%
|
|
Royal Perth Hospital
1 publication, 0.34%
|
|
Charles Sturt University
1 publication, 0.34%
|
|
Flinders Medical Centre
1 publication, 0.34%
|
|
Seoul National University
1 publication, 0.34%
|
|
Harvard University
1 publication, 0.34%
|
|
University of Washington
1 publication, 0.34%
|
|
Tufts University
1 publication, 0.34%
|
|
University of California, San Diego
1 publication, 0.34%
|
|
University of Minnesota
1 publication, 0.34%
|
|
University of Leeds
1 publication, 0.34%
|
|
Virginia Commonwealth University
1 publication, 0.34%
|
|
Emory University
1 publication, 0.34%
|
|
Mayo Clinic
1 publication, 0.34%
|
|
University of Pennsylvania
1 publication, 0.34%
|
|
University of Alberta
1 publication, 0.34%
|
|
University of Ottawa
1 publication, 0.34%
|
|
Florida Atlantic University
1 publication, 0.34%
|
|
University of Texas Health Science Center at Houston
1 publication, 0.34%
|
|
Show all (19 more) | |
2
4
6
8
10
12
14
16
|
Publishing organizations in 5 years
1
|
|
Tomsk National Research Medical Center of the Russian Academy of Sciences
1 publication, 0.51%
|
|
1
|
Publishing countries
10
20
30
40
50
60
|
|
China
|
China, 56, 19.05%
China
56 publications, 19.05%
|
USA
|
USA, 18, 6.12%
USA
18 publications, 6.12%
|
Italy
|
Italy, 8, 2.72%
Italy
8 publications, 2.72%
|
Australia
|
Australia, 7, 2.38%
Australia
7 publications, 2.38%
|
Brazil
|
Brazil, 6, 2.04%
Brazil
6 publications, 2.04%
|
Canada
|
Canada, 3, 1.02%
Canada
3 publications, 1.02%
|
Turkey
|
Turkey, 3, 1.02%
Turkey
3 publications, 1.02%
|
Sweden
|
Sweden, 3, 1.02%
Sweden
3 publications, 1.02%
|
United Kingdom
|
United Kingdom, 2, 0.68%
United Kingdom
2 publications, 0.68%
|
Israel
|
Israel, 2, 0.68%
Israel
2 publications, 0.68%
|
Germany
|
Germany, 1, 0.34%
Germany
1 publication, 0.34%
|
Argentina
|
Argentina, 1, 0.34%
Argentina
1 publication, 0.34%
|
India
|
India, 1, 0.34%
India
1 publication, 0.34%
|
Indonesia
|
Indonesia, 1, 0.34%
Indonesia
1 publication, 0.34%
|
Spain
|
Spain, 1, 0.34%
Spain
1 publication, 0.34%
|
Malaysia
|
Malaysia, 1, 0.34%
Malaysia
1 publication, 0.34%
|
New Zealand
|
New Zealand, 1, 0.34%
New Zealand
1 publication, 0.34%
|
Pakistan
|
Pakistan, 1, 0.34%
Pakistan
1 publication, 0.34%
|
Republic of Korea
|
Republic of Korea, 1, 0.34%
Republic of Korea
1 publication, 0.34%
|
Switzerland
|
Switzerland, 1, 0.34%
Switzerland
1 publication, 0.34%
|
10
20
30
40
50
60
|
Publishing countries in 5 years
2
4
6
8
10
12
14
16
18
|
|
China
|
China, 18, 9.18%
China
18 publications, 9.18%
|
Israel
|
Israel, 1, 0.51%
Israel
1 publication, 0.51%
|
India
|
India, 1, 0.51%
India
1 publication, 0.51%
|
Spain
|
Spain, 1, 0.51%
Spain
1 publication, 0.51%
|
Pakistan
|
Pakistan, 1, 0.51%
Pakistan
1 publication, 0.51%
|
Turkey
|
Turkey, 1, 0.51%
Turkey
1 publication, 0.51%
|
2
4
6
8
10
12
14
16
18
|
1 profile journal article
George Jacob
56 publications,
1 224 citations
h-index: 12
1 profile journal article
Ding Ding

University of Sydney
278 publications,
12 430 citations
h-index: 48
1 profile journal article
Zhenghao TANG
🥼 🤝
10 publications,
58 citations
h-index: 4